The University of Texas MD Anderson Cancer Center
ORCID: 0000-0002-5124-1811Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 11 papers. Top paper: “Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study”.
Robert J. Kreitman, Zev A. Wainberg, Y. Choi, Jan H.M. Schellens, Jean‐Charles Soria +9 more
Rena Vassilopoulou‐Sellin, Roland L. Bassett, Sireesha Yedururi, Mark Zafereo, Maria E. Cabanillas +4 more
Ali Dadbin, Ying C. Henderson, Elena McBeath Fujiwara, Clifford Stephan, Roza Nurieca +8 more
Jason Roszik, Filip Jankú, David S. Hong, Shumei Kato, Aung Naing +11 more
Mimi I. Hu, Maria E. Cabanillas, Jie Wu, Funda Meric‐Bernstam, Vivek Subbiah +1 more
Mohamed A. Gouda, J. Bryan Iorgulescu, Ramona Dadu, Keyur Patel, Steven I. Sherman +8 more
Sarah Hamidi, Rim Ouni, Rene Rico, Ying C. Henderson, M. Puche +8 more
Jason Roszik, Jibran Ahmed, Carmelia Maria Noia Barretto, Mirella Nardo, Erick Campbell +9 more
Alexander Augustyn, Abdallah Mohamed, Clifton D. Fuller, Adam S. Garden, Amy C. Moreno +17 more
Tao Shen, S. Terzyan, X. Liu, Xueqing Hu, Khadijah Patel +8 more
Rozita Bagheri‐Yarmand, Muthusamy Kunnimalaiyaan, Paola Miranda Mendez, Joseph L. Kidd, Ali Dadbin +18 more